AR012977A1 - Una composicion para utilizar en un inhalador en aerosol; uso de un componente de baja volatilidad; un inhalador en aerosol; un metodo dellenado de dicho inhalador en aerosol y particulas de aerosol emitidas por dicho inhalador en aerosol - Google Patents

Una composicion para utilizar en un inhalador en aerosol; uso de un componente de baja volatilidad; un inhalador en aerosol; un metodo dellenado de dicho inhalador en aerosol y particulas de aerosol emitidas por dicho inhalador en aerosol

Info

Publication number
AR012977A1
AR012977A1 ARP980102805A ARP980102805A AR012977A1 AR 012977 A1 AR012977 A1 AR 012977A1 AR P980102805 A ARP980102805 A AR P980102805A AR P980102805 A ARP980102805 A AR P980102805A AR 012977 A1 AR012977 A1 AR 012977A1
Authority
AR
Argentina
Prior art keywords
aerosol
inhaler
composition
low volatility
particles
Prior art date
Application number
ARP980102805A
Other languages
English (en)
Spanish (es)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR012977(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of AR012977A1 publication Critical patent/AR012977A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980102805A 1997-06-13 1998-06-12 Una composicion para utilizar en un inhalador en aerosol; uso de un componente de baja volatilidad; un inhalador en aerosol; un metodo dellenado de dicho inhalador en aerosol y particulas de aerosol emitidas por dicho inhalador en aerosol AR012977A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
AR012977A1 true AR012977A1 (es) 2000-11-22

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102805A AR012977A1 (es) 1997-06-13 1998-06-12 Una composicion para utilizar en un inhalador en aerosol; uso de un componente de baja volatilidad; un inhalador en aerosol; un metodo dellenado de dicho inhalador en aerosol y particulas de aerosol emitidas por dicho inhalador en aerosol

Country Status (44)

Country Link
EP (2) EP1219293A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP4380802B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100546239B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1138532C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR012977A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE222751T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU729966B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG63906B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9805993B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2263445C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO4940408A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ295521B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69807420T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0920302T4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DZ (1) DZ2516A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA001259B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE03664B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2182351T5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2326334A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GE (1) GEP20012462B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP980317B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU228487B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID21491A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL128484A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN189317B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS2435B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1293803B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA26507A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ME (2) MEP44008A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY119074A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO327775B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ334149A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL193721B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT920302E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (1) RS51274B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SA (1) SA98190821B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI0920302T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK284430B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN98087A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (1) TR199900288T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW555570B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA70289C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1998056349A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA985136B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
HRP20021025B1 (hr) * 2000-05-22 2013-11-22 Chiesi Farmaceutici S.P.A. Formulacije stabilnih farmaceutskih otopina za inhalatore s odmjerenom dozom pod tlakom
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
ATE465712T1 (de) 2002-03-01 2010-05-15 Chiesi Farma Spa Ultrafeine zusammensetzungen von formoterol
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc FULLY HALOGENATED FLUOROCARBON HYDROGEN AND HYDROFLUOROCHLOROUS HYDROGEN FUELS AND METHOD FOR THE PRODUCTION AND USE THEREOF
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL1809243T5 (pl) 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20110105449A1 (en) * 2007-11-07 2011-05-05 Astrazeneca R&D Dry powder formulations comprising ascorbic acid derivates
BR112013005284A2 (pt) * 2010-09-06 2019-09-24 Chiesi Farm Spa inalador dosimetrado e uso de um inalador dosimetrado
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
AU2017328908B2 (en) * 2016-09-19 2020-04-02 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601176B2 (en) † 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
WO1987005211A1 (en) † 1986-03-10 1987-09-11 Kurt Burghart Pharmaceutical preparation and process for producing the same
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
WO1992006675A1 (en) † 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP1092430B1 (en) † 1991-06-10 2003-08-06 Schering Corporation Non-chlorofluorocarbon aerosol formulations
IL102130A0 (en) † 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
WO1993011745A1 (en) * 1991-12-12 1993-06-24 Glaxo Group Limited Medicaments
PT1086688E (pt) * 1991-12-18 2004-06-30 Minnesota Mining & Mfg Formulacoes de aerossol em suspensao
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield Stabilisierte medizinische aerosollösungen
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
CA2189351C (en) † 1994-05-13 2008-12-30 Stephen J. Farr Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
WO1998024420A1 (en) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
ES2178817T3 (es) † 1997-02-05 2003-01-01 Jago Res Ag Formulaciones medicinales de aerosol.

Also Published As

Publication number Publication date
DZ2516A1 (fr) 2004-11-08
SA98190821B1 (ar) 2006-11-19
CN1229355A (zh) 1999-09-22
EE9900055A (et) 1999-08-16
CA2263445C (en) 2008-09-09
WO1998056349A1 (en) 1998-12-17
EP0920302B1 (en) 2002-08-28
AU729966B2 (en) 2001-02-15
SK17699A3 (en) 1999-07-12
ES2182351T3 (es) 2003-03-01
IN189317B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2003-02-08
BR9805993A (pt) 1999-08-31
CN1138532C (zh) 2004-02-18
HRP980317B1 (en) 2002-06-30
TR199900288T1 (xx) 1999-09-21
PT920302E (pt) 2002-11-29
EP1219293A2 (en) 2002-07-03
GB9712434D0 (en) 1997-08-13
DE69807420T3 (de) 2006-11-16
NO990594D0 (no) 1999-02-09
DE69807420D1 (de) 2002-10-02
CO4940408A1 (es) 2000-07-24
UA70289C2 (uk) 2004-10-15
HK1022271A1 (en) 2000-08-04
HUP0001339A3 (en) 2000-10-30
IL128484A (en) 2004-09-27
CA2263445A1 (en) 1998-12-17
NO327775B1 (no) 2009-09-21
GB2326334A (en) 1998-12-23
HRP980317A2 (en) 1999-04-30
HU228487B1 (en) 2013-03-28
NZ334149A (en) 2000-07-28
ITMI971798A1 (it) 1999-01-28
HUP0001339A2 (hu) 2000-09-28
SI0920302T2 (sl) 2006-10-31
ID21491A (id) 1999-06-17
IS4974A (is) 1999-02-11
SK284430B6 (sk) 2005-04-01
EP1219293A3 (en) 2003-05-28
MA26507A1 (fr) 2004-12-20
SI0920302T1 (en) 2002-12-31
ATE222751T1 (de) 2002-09-15
BG63906B1 (bg) 2003-06-30
IT1293803B1 (it) 1999-03-10
CZ46299A3 (cs) 1999-07-14
ME00333B (me) 2011-02-10
IL128484A0 (en) 2000-01-31
EP0920302A1 (en) 1999-06-09
PL331531A1 (en) 1999-07-19
AU8626298A (en) 1998-12-30
ZA985136B (en) 1999-01-07
TW555570B (en) 2003-10-01
YU6999A (sh) 2000-03-21
IS2435B (is) 2008-10-15
ES2182351T5 (es) 2007-03-16
EA199900201A1 (ru) 1999-06-24
RS51274B (sr) 2010-12-31
MY119074A (en) 2005-03-31
BG103221A (en) 1999-09-30
EP0920302B2 (en) 2006-06-21
KR100546239B1 (ko) 2006-01-26
JP2000516965A (ja) 2000-12-19
DK0920302T4 (da) 2006-10-09
KR20000068171A (ko) 2000-11-25
MEP44008A (en) 2011-02-10
JP4380802B2 (ja) 2009-12-09
PL193721B1 (pl) 2007-03-30
DK0920302T3 (da) 2002-12-23
EE03664B1 (et) 2002-04-15
NO990594L (no) 1999-04-13
DE69807420T2 (de) 2003-05-08
TNSN98087A1 (fr) 2005-03-15
EA001259B1 (ru) 2000-12-25
GEP20012462B (en) 2001-06-25
BR9805993B1 (pt) 2009-05-05
CZ295521B6 (cs) 2005-08-17

Similar Documents

Publication Publication Date Title
AR012977A1 (es) Una composicion para utilizar en un inhalador en aerosol; uso de un componente de baja volatilidad; un inhalador en aerosol; un metodo dellenado de dicho inhalador en aerosol y particulas de aerosol emitidas por dicho inhalador en aerosol
MX9302140A (es) Composicion aerosol antiperspirante con alto contenido de solidos.
DE69432224D1 (de) Aerosole als darreichungsform mit cfc-freiem treibmittel
AR057697A1 (es) Composiciones de pulverizacion
ES2530390T3 (es) Vehículo espumante de ácido carboxílico y composiciones farmacéuticas del mismo
MX2007010893A (es) Composiciones espumantes de alto contenido de alcohol con agentes tensioactivos basados en silicon.
AR029523A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
GB9511669D0 (en) Stabilized medicinal aerosol solution formulations
AR011611A1 (es) Composiciones en gel postespumante
EA200401006A1 (ru) Аэрозольные препараты для внутрилёгочного введения лекарств с получением системного действия
DK0553298T3 (da) Aerosolformulering omfattende beclomethason-17,21-dipropionat
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
AR008309A1 (es) Formulaciones de aerosol en suspensión de furoato de mometasona , usos de de las mismas e inhalador de dosis de medida
AR246160A1 (es) Preservativo para composiciones acuosas.
IT1317720B1 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
US3287214A (en) Surface disinfectant and space deodorant aerosol spray compositions
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
ES2178131T3 (es) Composicion cosmetica de esmalte a base de nitrocelulosa que contiene un agente estabilizante.
ES2120461T3 (es) Composicion plaguicida.
ES2062360T3 (es) Composiciones de aerosol para aplicacion topica.
MX9301410A (es) Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.
ES2357937T1 (es) Composiciones que contienen olefinas sustituidas con fluor.
GB1070304A (en) Hair setting compositions
ES291935A1 (es) Mejoras y perfeccionamientos en el prodcedimiento de propulsiën de aerosoles

Legal Events

Date Code Title Description
FC Refusal